Nancy Dvorin

Managing Editor

20 Years of Experience

About

@NancyDvorin has been covering and analyzing the medical device and pharmaceutical industries for more than 20 years. Prior to joining MedTech Strategist, she was the managing editor of several life sciences business publications including In Vivo and Medtech Insight. Earlier in her career, Nancy managed library and information services for a number of multinational corporations.

Articles from Nancy Dvorin:

Perspective & Commentary

Digital Edition: MedTech Strategist May 2025

How emerging companies are using AI to predict an individual patient's cardiac risk and increase the availability of high-quality cardiovascular disease management; Johns Hopkins Medicine's T.Y. Alvin Liu on how the JHM healthcare system is creating a governance model for developing best practices in AI; Expert insights into the current funding environment for early-stage medtechs; and new data on US healthcare expenditure by condition.

Read Article